Dapablix/Dapablix Met

  • Dapablix/Dapablix Met 1
  • Dapablix/Dapablix Met 2
Product Description

Dapablix contains dapagliflozin, an SGLT2 inhibitor that effectively reduces blood glucose levels by promoting renal glucose excretion. It is indicated for the management of type 2 diabetes mellitus, offering additional benefits such as weight reduction and cardiovascular risk mitigation.
Dapablix Met combines dapagliflozin, an SGLT2 inhibitor, and metformin, a biguanide, to enhance glycemic control in patients with type 2 diabetes. This dual mechanism targets both renal glucose excretion and hepatic glucose production, providing effective blood sugar management. Dapablix Met supports weight reduction and has a proven safety profile, making it a preferred option for comprehensive diabetes care.

Read more Show less

Alesraa Pharmaceutical Optime

  • Country/Region:
    Egypt
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Cosmeceuticals
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Film-Coated Tablets, Extended-release Film-Coated tablets
  • Supplied from
    Egypt
More specifications Fewer specifications
Sales Markets
Show more Show less

Alesraa Pharmaceutical Optime

  • Country/Region:
    Egypt
  • On CPHI since:
    2024
  • Certificates:
    2
  • Employees:
    500 - 999
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Contract Manufacturer
Cosmeceuticals
Nutraceuticals
Pharmaceutical Company (generic finished products)
View company profile

More Products from Alesraa Pharmaceutical Optime (2)

  • Allergicasone

    Product Allergicasone

    Allergicasone combines 125 mg of azelastine, a potent antihistamine, and 50 mcg of fluticasone propionate, a powerful corticosteroid, to provide comprehensive relief from allergic rhinitis symptoms. The dual-action formula targets both histamine release and inflammation, effectively reducing nasal congesti...
  • Larosuzet

    Product Larosuzet

    Larosuzet integrates the strengths of ezetimibe, an intestinal cholesterol absorption inhibitor, and rosuvastatin, an HMG-CoA reductase inhibitor, to achieve optimal lipid control. This dual-action formula reduces LDL-C and total cholesterol levels more effectively than either agent alone. Larosuzet is sui...